Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLEX 404 + Gemcitabine in Advanced Pancreatic Cancer
NCT03301805Phase 2Not yet recruiting
- Sponsor
- Rgene
- Start
- Jul 2026
- Primary completion
- Apr 2027
- Modality
- Botanical drug
01
Overview
A Phase 2 trial of bli-1401 in pancreatic cancer (PC), sponsored by Rgene. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
bli-1401
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT03301805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03301805.